Evidence map›Paper›PMID 40644376›Full record

ArticlePLOS global public health2025

Analysis of COVID-19 vaccination experience of the Los Pastos, Wounaan, and Misak Misak indigenous peoples from Bogotá, Colombia.

Sandra Vargas-Cruz, Miguel Baquero-Acuña, Camila Bautista, Juan Castro-Caro, Nicol Espejo, Pedro Ruiz Mateus, Irene Parra-García

Abstract read
In one paragraph

Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sandra Vargas-CruzFaculty of Medicine, Universidad El Bosque, Bogotá, Colombia.
Miguel Baquero-AcuñaFaculty of Medicine, Universidad El Bosque, Bogotá, Colombia.
Camila BautistaFaculty of Medicine, Universidad El Bosque, Bogotá, Colombia.
Juan Castro-CaroFaculty of Medicine, Universidad El Bosque, Bogotá, Colombia.
Nicol EspejoFaculty of Medicine, Universidad El Bosque, Bogotá, Colombia.
Pedro Ruiz MateusFaculty of Medicine, Universidad El Bosque, Bogotá, Colombia.
Irene Parra-GarcíaHumanities Department, Universidad El Bosque, Bogotá, Colombia.ORCID https://orcid.org/0000-0002-1993-1783

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coronavirus disease 2019 (COVID-19) pandemic was recognized as a public health crisis closely linked to socioeconomic and cultural factors. Vaccination is a long-term solution for COVID-19; however, access to vaccines has been hindered by geographic, cultural, and socioeconomic barriers as well as distrust in the health system-particularly among populations that have experienced historical inequities, such as indigenous peoples. This study aimed to analyze the COVID-19 vaccination experiences of the Misak Misak, Wounaan, and Los Pastos indigenous peoples in Bogotá, Colombia. This was a sequential explanatory mixed-methods study, with the quantitative phase followed by the qualitative phase. We conducted emistructured interviews, 9 sharing circles, and 85 household surveys using a triangulation approach. Results showed that the Los Pastos people had the highest vaccination rate (97.3%), followed by the Misak Misak people (85.2%); the Wounaan people had the lowest vaccination rate (38.5%). The main reason for vaccination among the Misak Misak and Wounaan was that it was mandated by their workplaces or educational institutions. For the Los Pastos, the main reason for vaccination was to protect themselves and their environment. The main reasons for not getting vaccinated included distrust of vaccines, although there were no geographic access barriers. This study revealed varying vaccination rates among indigenous populations living in urban areas, possibly associated with factors such as infodemic, previous distrust of Western health services, and preference for ancestral medicine as an alternative for COVID-19 prevention.

Identifiers

PMID40644376
PMCPMC12250578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.